Stay updated with breaking news from Crossover Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data Expected in March 2023SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC, OTC:ENSCW), a clinical-stage biotech company applying transformative
~ Critical Study to Support Abuse Deterrent Labeling ~SAN DIEGO, CA / ACCESSWIRE / October 28, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage
~ Oral Opioid Abuse Being Explored for PF614 ~~ Data From Trial Supports Abuse Deterrent Labeling, Designed to Measure the Potential for Drug Liking ~SAN DIEGO, CA / ACCESSWIRE / September 22, 2022 / Ensysce
People with prescriptions for the lifesaving medication often don't carry their auto-injectors, and many hesitate to use them.
Chincal trial hookin looking at cannabis and autism. >> the first study was an open label study. we knew that there will be some placebo effect, but we were surprised that most parents reported that it substantially helped their children, not only for the disruptive behavior, but also for the social deficit. >> doctors like igor grant in california were paying attention. intrigued by the findings of this early research. >> quite a bit of data came out of israel. so this is some evidence that cbd may be helpful. >> so grant and dr. doris trauner launched their own study with cbd and autism here...